Selected article for: "immune response and secondary pneumonia"
Author: Yang, Chunxiu; Xiao, Shu-Yuan
Title: COVID-19 and inflammatory bowel disease: a pathophysiological assessment
  • Cord-id: rh7882gk
  • Document date: 2021_1_5
    • ID: rh7882gk
    Snippet: Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, has led to the ongoing global pandemic. Although most patients experience no or only mild symptoms, some patients can develop severe illness, such as progressive pneumonia, acute respiratory distress syndrome, secondary hemophagocytic lymphohistiocytosis and multiple organ failure caused by cytokine release syndrome. A majority of COVID-19 patients also develop gastrointestinal symptoms. These can present special challenges to the manage
    Document: Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, has led to the ongoing global pandemic. Although most patients experience no or only mild symptoms, some patients can develop severe illness, such as progressive pneumonia, acute respiratory distress syndrome, secondary hemophagocytic lymphohistiocytosis and multiple organ failure caused by cytokine release syndrome. A majority of COVID-19 patients also develop gastrointestinal symptoms. These can present special challenges to the management of patients with inflammatory bowel disease (IBD) due to potential interactions between the immune response related to SARS-CoV-2 infection and dysregulated immunity associated with IBD. In this context, the pathogenesis of COVID-19 is reviewed in order to address these questions regarding immune interactions between COVID-19 and IBD.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and active phase: 1, 2
    • abdominal pain and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and liver function test: 1
    • abdominal pain and long period: 1, 2
    • abdominal pain and loss vomiting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • abdominal pain and loss vomiting nausea: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • abdominal pain and loss vomiting nausea diarrhea: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and loss vomiting nausea diarrhea abdominal pain: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and macrophage activation: 1, 2, 3, 4
    • abdominal pain and macrophage activation syndrome: 1, 2, 3, 4
    • abundant release and macrophage activation: 1
    • active phase and acute ards respiratory distress syndrome: 1
    • active phase and adaptive immune response: 1